Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2023 ▲▼ | Q2 2023 ▲▼ | Change ▲▼ | Q1 2023 ▲▼ | Q2 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| VERVE THERAPEUTICS, INC. | 2,008,809 | 2,008,809 | 0 | 28,967 | 37,665 | 23.26% | +8,698 |
| UNITY BIOTECHNOLOGY, INC. | 1,004,817 | 1,004,817 | 0 | 1,638 | 2,562 | 1.58% | +924 |
| SINGULAR GENOMICS SYSTEMS, INC. | 3,798,926 | 3,798,926 | 0 | 4,597 | 3,153 | 1.95% | -1,444 |
| ERASCA, INC.(ERAS) | 11,055,554 | 11,055,554 | 0 | 33,277 | 30,513 | 18.84% | -2,764 |
| EQRX, INC. | 36,335,375 | 36,335,375 | 0 | 70,491 | 67,584 | 41.73% | -2,907 |
| NATERA, INC. | 64,441 | 0 | -64,441 | 3,578 | 0 | — | -3,578 |
| KARUNA THERAPEUTICS, INC. | 30,000 | 0 | -30,000 | 5,449 | 0 | — | -5,449 |
| DENALI THERAPEUTICS, INC.(DNLI) | 2,568,749 | 693,749 | -1,875,000 | 59,184 | 20,473 | 12.64% | -38,711 |